iMmune SignAtures and Clinical outComes in AP — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

iMmune SignAtures and Clinical outComes in AP — Stella

Home/Acute Pancreatitis/

View on ClinicalTrials.gov

Recruiting

Back to Acute Pancreatitis trials

Trial locations(5 sites)

United States

University of Southern California, Los Angeles, California

University of Illinois Chicago, Chicago, Illinois

The Ohio State University, Columbus, Ohio

University of Pittsburgh, Pittsburgh, Pennsylvania

Benaroya Research Institute, Seattle, Washington

Key details

Sponsor

Ohio State University

Collaborators

University of Pittsburgh, University of Illinois at Chicago

Enrollment target

~198 participants

Started

March 2023

Primary completion

December 2026

Age range

18 Years – 75 Years

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.